欢迎光临源叶生物,登录 | 注册 |
当前位置: 首页 > 小分子抑制剂 > Apoptosis > PD1-PDL1 inhibitor 1

浏览历史

S80448

PD1-PDL1 inhibitor 1

源叶(MedMol) 99%
  • 英文名:
  • PD1-PDL1 inhibitor 1
  • 别名:
  • CAS号:
  • 1675201-83-8
  • 分子式:
  • C29H33NO5
  • 分子量:
  • 475.576
  • 核磁/质谱:
品牌货号产品规格价格(RMB) 库存(上海) 北京 武汉 南京 数量计量单位 加入购物车...
源叶(MedMol) S80448-1mg 99% ¥144.00元 3 - - - EA 加入购物车
源叶(MedMol) S80448-2mg 99% ¥280.00元 7 - - - EA 加入购物车
源叶(MedMol) S80448-5mg 99% ¥640.00元 4 - - - EA 加入购物车
源叶(MedMol) S80448-10mg 99% ¥1120.00元 5 - - - EA 加入购物车
源叶(MedMol) S80448-25mg 99% ¥2240.00元 6 - - - EA 加入购物车
源叶(MedMol) S80448-100mg 99% ¥3248.00元 5 - - - EA 加入购物车
大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》,到货后将短信提示。
提交

产品介绍

参考文献(1篇)

质检证书(COA)

摩尔浓度计算器

相关产品

  • 提示:详情请下载说明书。
  • 产品描述: BMS-1 (PD-1/PD-L1 inhibitor 1, PD1-PDL1-IN1)是一种PD-1/PD-L1相互作用的小分子化合物抑制剂,IC50为6 nM
  • 靶点: PD-1/PD-L1 interaction(Cell-free assay):0.006 μM;Apoptosis;PD-1/PD-L1
  • 体外研究:
    PD-1/PD-L1 inhibitor 1 causes half-reduced cell viability at lower concentrations in triple-negative breast cancer (TNBC), activates ERK in MDA-MB-231 and MCF7, significantly increases IL-8 expression in MDA-MB-231 and HCC1806 when administrated in combination with ERK1/2 inhibitor, also potently downregulates the IL-8 expression to its half amount in MDA-MB-231
  • 体内研究:
    PD-1/PD-L1 inhibitor 1 combined with Jiedu Sangen Decoction (JSD) remarkably inhibits and reverses epithelial-mesenchymal transition (EMT) via PI3K/AKT signaling pathway
  • 细胞实验: Cell lines: MDA-MB-231 cells, HCC1937 cells, HCC1806 cells, MCF7 cells Concentrations: -- Incubation Time: 72 h Method: Cell proliferation is determined by the MTS assay. A total of 1-2×103 cells are plated in 100 μl medium in each well of a 96-well plate. After 24 h, PD-1/PD-L1 inhibitor 1 and ERK1/2 inhibitor are diluted to the desired concentrations in test medium (DMEM containing 1% fetal bovine serum) and added as single or as combined treatment in triplicate for 72 h.
  • 动物实验: Animal Models: Male specific pathogen free BALB/c mice of hepatic metastatic colorectal cancer (CRC) model Dosages: 100 µg Administration: i.p.
  • 参考文献:
    1. WO/2015/034820, COMPOUNDS USEFUL AS IMMUNOMODULATORS. 2. Bräutigam K, et al. Inhibitors of PD-1/PD-L1 and ERK1/2 impede the proliferation of receptor positive and triple-negative breast cancer cell lines. J Cancer Res Clin Oncol. 2021;147(10):2923-2933. 3. Shan, Feiyu et al. Inhibition to Epithelial-Mesenchymal Transition and Metastatic Potential In Colorectal Cancer Cell By Combination of Traditional Chinese Medicine Formulation Jiedu Sangen Decoction and PD-L1 Inhibitor. Integrative cancer therapies vol. 19 (2020): 1534735420972486.
  • 溶解性: Soluble  in  DMSO、Ethanol、H2O
  • 保存条件: -20℃
  • 配置溶液浓度参考:
    1mg 5mg 10mg
    1 mM 2.103 ml 10.514 ml 21.027 ml
    5 mM 0.421 ml 2.103 ml 4.205 ml
    10 mM 0.21 ml 1.051 ml 2.103 ml
    50 mM 0.042 ml 0.21 ml 0.421 ml
  • 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:


质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)


  • =
    *
    *


源叶所有产品仅用作科学研究,销售产品行为均适用于我司网上所列通用销售条款。